Technical University of Munich: Therapeutic Vaccine for Hepatitis B Enters First Clinical Trial
July 25, 2025
July 25, 2025
MUNICH, Germany, July 25 -- The Technical University of Munich issued the following news:
* * *
Treatment for chronic hepatitis B tested on patients for the first time
Therapeutic vaccine for hepatitis B enters first clinical trial
*
TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient was enrolled in June 2025 and treated with the vaccine. In a previous trial . . .
* * *
Treatment for chronic hepatitis B tested on patients for the first time
Therapeutic vaccine for hepatitis B enters first clinical trial
*
TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient was enrolled in June 2025 and treated with the vaccine. In a previous trial . . .